Minimally Invasive Thoracic Surgery Summit

Transcription

1 3 rd INTERNATIONAL BIENNIAL Minimally Invasive Thoracic Surgery Summit The Joseph B. Martin Conference Center at 77 Avenue Louis Pasteur October 7-8, Symposium Director and Supplement Guest Editor Co-Symposium Directors Jon Wee, MD Raphael Bueno, MD Faculty: Monica Bertagnolli, MD, Phillip C. Camp, MD, Lucian Chirieac, MD, Yolonda L. Colson, MD, PhD, Thomas D Amico, MD, Durham, NC Todd Demmy, MD, FACS, Buffalo, NY Christopher Ducko, MD, Hiran C. Fernando, MD, MBBS, FRCS, Sidharta P. Gangadharan, MD, Henrik Hansen, MD, Copenhagen, Denmark Francine Jacobson, MD, MPH, Michael T. Jaklitsch, MD, Bruce E. Johnson, MD, Kemp Kernstine, MD, PhD, Duarte, CA Rodney J. Landreneau, MD, Pittsburgh, PA Abraham Lebenthal, MD, Michael Maddaus, MD, Minneapolis, MN M. Blair Marshall, MD, FACS, Washington, DC Robert J. McKenna, Jr., MD, Los Angeles, CA Ciaran McNamee, MD, Steven J. Mentzer, MD, Bryan F. Meyers, MD, MPH, St. Louis, MO Daniel L. Miller, MD, Atlanta, GA Christopher R. Morse, MD, Gaetano Rocco, MD, FRCS, Naples, Italy David J. Sugarbaker, MD, Robert D. Timmerman, MD, Dallas, TX Masahiro Tsuboi, MD, Tokyo, Japan William Walker, MD, Edinburgh, Scotland The American Association for

2 3 rd International Biennial MITSS Overview The 3rd International Minimally Invasive Summit is the first to bring together a group of thoracic surgeons dedicated to the field of minimally invasive general thoracic surgery. The goal is to present the current state-of-the art, give insight and data, based on the faculty s experience on where the field is heading. The agenda discusses a range of topics presented by leaders in the field. Pertaining to lung cancer, these include minimally invasive approaches to lung cancer treatment, lung cancer screening, and new developments in lung cancer molecular biology. The workup and staging of esophageal cancer and benign esophageal disorders as well as the best treatment for esophageal malignancy are highlighted. Minimally invasive approaches to the mediastinum are reviewed. For each area, the potential for application of the robot is featured. A fascinating section focuses on new developments in technology, including stent therapy, navigational bronchoscopy, lung localization options, sentinel node identification in lung cancer, and ablative and innovative radiation techniques. The lectures are an outstanding compilation of the most up-to-date information in the field of minimally invasive thoracic surgery in the world today. Please join us October 7th and 8th, 2011 in Boston. Sincerely,

3 FACULTY Monica Bertagnolli, MD Chief, Division of Surgical Oncology Group Chair, CALGB Raphael Bueno, MD Associate Chief, Division of Associate Phillip C. Camp, MD Director, Lung Transplant Program Lucian Chirieac, MD Staff Pathologist Associate Professor of Pathology Yolonda L. Colson, MD, PhD Director, Women s Lung Cancer Program Associate Thomas D Amico, MD Program Director, Medical Director, Clinical Oncology Duke University Medical Center Duke University Medical School Durham, NC Todd Demmy, MD, FACS Clinical Chair, Department of Roswell Park Cancer Institute Professor of Oncology Associate and Clinical Scholar University at Buffalo Medical School Buffalo, NY Christopher Ducko, MD Instructor in Surgery Hiran C. Fernando, MD, MBBS, FRCS Director, Center for Minimally Invasive Esophageal Surgery Boston Medical Center Associate Professor of Cardiothoracic Surgery Boston University School of Medicine Sidharta P. Gangadharan, MD Acting Chief, Beth Israel Deaconness Medical Center Assistant Henrik Hansen, MD Gentofte Hospital Copenhagen, Denmark Francine Jacobson, MD, MPH Department of Radiology Asssitant Professor of Radiology Michael T. Jaklitsch, MD Associate Bruce E. Johnson, MD Program Director, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute Professor of Clinical Oncology Kemp Kernstine, MD, PhD Chief, Director, Lung Cancer and Oncology Program City of Hope National Medical Center Beckman Research Institute Duarte, CA Rodney J. Landreneau, MD Director, Comprehensive Lung Center University of Pittsburgh Medical Center Shadyside Director, Lung Cancer Program Department of Cardiothoracic Surgery University of Pittsburgh Medical Center University of Pittsburgh Medical School Pittsburgh, PA Abraham Lebenthal, MD Michael Maddaus, MD Professor and Chief, Division of Thoracic and Foregut Surgery Program Director, General Surgery Co-Director, Minimally Invasive Surgery Center Garamella Lynch Jensen Chair in Thoracic and Cardiovascular Surgery University of Minnesota Department of Surgery and Masonic Cancer Center Minneapolis, MN M. Blair Marshall, MD, FACS Chief, Georgetown University Hospital Associate Georgetown University Medical Center Washington, DC Robert J. McKenna, Jr., MD Chief, Medical Director, and Trauma Program Director, General Thoracic Surgery Fellowship Surgical Director, Women s Guild Lung Institute Cedars-Sinai Medical Center Professor of UCLA David Geffen Medical School Los Angeles, CA Ciaran McNamee, MD Instructor in Surgery Steven J. Mentzer, MD Bryan F. Meyers, MD, MPH Chief, Williamson Endowed Chair in Cardiothoracic Surgery Director, Lung Volume Reduction Program Washington University-Barnes Jewish Hospital Washington University Medical Center St. Louis, MO Daniel L. Miller, MD Kamal A. Mansour Chief, General Surgical Director, Thoracic Oncology Program Emory University Hospital Emory University Medical School Atlanta, GA Christopher R. Morse, MD Massachusetts General Hospital Instructor in Surgery Gaetano Rocco, MD, FRCS Head, Department of Thoracic Surgery and Oncology National Cancer Institute, Pascale Foundation Naples, Italy David J. Sugarbaker, MD Richard E. Wilson Professor of Surgical Oncology Chief, Scott J. Swanson, MD Director of Minimally Invasive Chief Surgical Officer Dana-Farber Cancer Institute Robert D. Timmerman, MD Effie Marie Cain Distinguished Chair in Cancer Therapy Research Director of Clinical Research Professor of Radiation Oncology and Neurosurgery University of Texas Southwestern Medical Center Dallas, TX Masahiro Tsuboi, MD Department of and Oncology Tokyo Medical University and Hospital Tokyo, Japan William Walker, MD Department of Royal Infirmary of Edinburgh The Royal College of Surgeons Edinburgh, Scotland Jon O. Wee, MD Co-Director of Minimally Invasive Instructor in Surgery

4 PROGRAM Friday, October 7, :00 AM breakfast/registration 7:30 AM INTRODUCTORY REMARKS and Welcome SESSION I: Lung Cancer Diagnosis and Staging Moderators: Todd Demmy, MD and Christopher Ducko, MD 8:00 AM Lung Cancer Screening Trials Denmark, United States and Beyond Henrik Hansen, MD and Francine Jacobson MD 8:20 AM Debate PET Scan is of Critical Importance in Workup of Lung Cancer Pro: Thomas D Amico, MD Con: William Walker, MD 8:40 AM EBUS What s Its Role and Who Should Do It? Michael Maddaus, MD 9:00 am VAMLA Should Be The New Standard Todd Demmy, MD 9:20 AM What Is the Surgeon s Role in Molecular Biology? Gaetano Rocco, MD 9:40 am Panel Discussion 10:00 am Coffee Break SESSION II: Lung Cancer Treatment Moderators: William Walker, MD and Michael Jaklitsch, MD 10:30 AM Best Operation for Small Early Stage Lung Cancer VATS Wedge Rodney Landreneau, MD VATS Segment Thomas D Amico, MD VATS Lobe Michael Maddaus, MD Robotic Lobe Kemp Kernstine, MD 11:20 AM Clinical Trials for Early Stage Lung Cancer CALGB Todd Demmy, MD JCOG 0802 Masahiro Tsuboi, MD ACOSOG SRS Hiran Fernando, MD 11:50 AM One Port VATS Resections A Clear Advance Gaetano Rocco, MD 12:05 pm VATS Lymphadenectomy Sidharta Gangadharan, MD 12:20 pm Panel Discussion SESSION III: Lung Cancer Other Considerations Moderators: Yolonda Colson, MD and Henrik Hansen, MD 1:30 PM Radiation Therapy Is The Way To Cure Early Stage Lung Cancer Robert Timmerman, MD and Bryan Meyers, MD 1:45 PM Navigational Bronchoscopy and RFA- Two Excellent Adjunctive Technologies Jon Wee, MD 2:00 PM Adjuvant Chemotherapy Bottom Line for the Surgeon Bruce Johnson, MD 2:15 pm Pathology of Lung Adenocarcinoma Lucian Chirieac, MD 2:30 pm Panel Discussion 2:50 pm Coffee Break SESSION IV: Training / Education / Technology Moderators: Abraham Lebenthal, MD and Gaetano Rocco, MD 3:15 pm Simulation M. Blair Marshall, MD 3:30 pm Energy and Sealants Rodney Landreneau, MD 3:45 pm Chest Wall Resection and Reconstruction Todd Demmy, MD / Daniel Miller, MD 4:00 pm VATS 1st Rib Resection Robert McKenna, MD 4:15 pm VATS Thymectomy 4:30 pm Tracheoplasty Sidharta Gangadharan, MD 4:45 pm Approach To Training United Kingdom William Walker, MD Italy Gaetano Rocco, MD Denmark Henrik Hansen, MD United States Thomas D Amico, MD 5:25 pm Panel Discussion 5:45 pm Adjourn 12:40 pm Lunch

5 PROGRAM Saturday, October 8, :15 AM CONTINENTAL BREAKFAST 8:00 AM INTRODUCTORY REMARKS SESSION V: Video Most Instructive ComplicationS/ Teaching Points Moderators: and M. Blair Marshall, MD 8:10 am Thomas D Amico, MD 8:20 am Daniel Miller, MD 8:30 am Robert McKenna, Jr. MD 8:40 am Henrik Hansen, MD 8:50 am Todd Demmy, MD 9:00 am Michael Maddaus, MD 9:10 am 9:20 AM Panel Discussion 9:30 am Coffee Break SESSION VI: Malignant Esophagus Moderators: Daniel Miller, MD and Ciaran McNamee, MD 10:00 am Barrett s Dysplasia / CIS Dan Miller, MD 10:15 am Ivor Lewis MIE Jon Wee, MD and Christopher Morse, MD 10:35 am 3-Hole MIE Raphael Bueno, MD 10:50 am Robotic Esophagectomy Kemp Kernstine, MD 11:05 am Chylothorax Steven Mentzer, MD Leak Bryan Meyers, MD Reflux Michael Maddaus, MD 11:35 am Panel Discussion 11:50 am Lunch SESSION VII: Esophagus Benign Moderators: Raphael Bueno, MD and Hiran Fernando, MD 12:35 PM IANT Para-Esophageal Hernia Repair Technical Pearls Michael Maddaus, MD 12:50 PM Redo Laparoscopic Repair for Benign Esophageal Disease Raphael Bueno, MD 1:05 PM Transoral Incisionless Fundoplication for GERD Jon Wee, MD and Hiran Fernando, MD 1:25 pm Esophageal Perforation Daniel Miller, MD 1:40 pm Panel Discussion 2:00 pm Coffee Break SESSION VIII: Innovation and the Future Moderators: Michael Maddaus, MD and Daniel Cohen, MD 2:30 PM State of the Clinical Trials System and the NCI Monica Bertagnolli, MD 2:50 PM Intraoperative Chemotherapy How To Do It and Potential Applications David Sugarbaker, MD 3:05 pm Sentinel Lymph Node Evaluation Yolonda Colson, MD 3:20 pm Ex-Vivo Lung Perfusion Michael Jaklitsch, MD and Phillip Camp, MD 3:35 PM Cost of Health Care What Difference Does It Make? Bryan Meyers, MD 3:50 PM The Politics of Medicine Views from Inside the Beltway M. Blair Marshall, MD 4:05 pm Panel Discussion 4:20 pm Closing Remarks 4:30 pm Adjourn

6 CME ACCREDITATION EDUCATIONAL GOAL: Upon completion of this activity, participants will have a greater appreciation for new diagnostic and surgical techniques as well as in thoracic disease. TARGET AUDIENCE: Thoracic Surgeons, Pulmonologists, Gastroenterologists, Internal Medicine Specialists, Primary Care Physicians, Residents and Fellows, Nurses, Physician Assistants and other Allied Healthcare Professionals. CME ACCREDITATION: The American Association for is accredited by the Accreditation Council forcontinuing Medical Education to provide continuing medical education for physicians. The American Association for designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. EDUCATIONAL OBJECTIVES: Apply staging and resection strategies for the treatment of malignant and benign esophageal disease. Describe various surgical approaches to the treatment of mediastinum and chest wall procedures. Analyze advanced technologies in minimally invasive thoracic surgery and bronchoscopy. Identify appropriate procedures for lung cancer screening. Integrate several surgical procedures for the surgical treatment of lung cancer. Determine staging and resection strategies for the treatment of lung cancer. DISCLOSURE POLICY: It is the policy of the American Association for that any individual who is involved in planning, presenting or is an author on a program designated for AMA Physician s Recognition Award Category 1 Credit must disclose any financial interest or other relationship (grant, research support, consultant, etc.) that individual has with any manufacturer(s) of any commercial product(s) that may be discussed in the individual s presentation. This information is disclosed to the audience prior to an activity. The AATS has procedures in place if a conflict of interest should arise. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceutical or medical device occurs. For further information on the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, please visit

7 3rd International Biennial MITSS Registration Form To register for this summit, complete this form and return it to Ciné-Med with payment by September 15, 2011, fax form with credit card information to , or register online at Name Affiliation Mailing Address City, State, Zip Phone FAX Degree Registration Fees: Register before September 1, 2011: $500 Register after September 1, 2011: $650 There will be a $25.00 processing fee charged for cancellations. No refund for cancellations within 10 days of the summit. Credit card MasterCard VISA AmEx Account number Expiration date Sec code Signature Questions For questions or special needs, please contact Caren Genovese at (800) or [email protected] Mail registration for with payment to Ciné-Med, Inc., P.O. Box 745, Woodbury, CT Accommodations mention MITSS Course when you make your reservation A limited block of rooms are available at the following hotels: Boston Marriott Copley Place: (617) Westin Hotel Copley Place Boston: (617) Radisson Hotel Boston: (617) Best Western - The Inn at Longwood Medical Center: (617) For other Boston area hotels, look online at Register online at

8 PO Box 745 Woodbury, CT PRST STD US POSTAGE PAID Waterbury, CT PERMIT NO 411